Ocuphire Pharma Inc (OCUP)
2.03
+0.04
(+2.01%)
USD |
NASDAQ |
May 06, 14:39
Ocuphire Pharma Market Cap: 50.37M for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 49.38M |
| May 02, 2024 | 45.90M |
| May 01, 2024 | 40.69M |
| April 30, 2024 | 39.33M |
| April 29, 2024 | 40.94M |
| April 26, 2024 | 39.95M |
| April 25, 2024 | 38.09M |
| April 24, 2024 | 37.96M |
| April 23, 2024 | 38.21M |
| April 22, 2024 | 37.47M |
| April 19, 2024 | 41.07M |
| April 18, 2024 | 41.44M |
| April 17, 2024 | 43.18M |
| April 16, 2024 | 43.18M |
| April 15, 2024 | 43.67M |
| April 12, 2024 | 45.66M |
| April 11, 2024 | 44.42M |
| April 10, 2024 | 46.15M |
| April 09, 2024 | 46.15M |
| April 08, 2024 | 45.41M |
| April 05, 2024 | 47.39M |
| April 04, 2024 | 46.65M |
| April 03, 2024 | 48.14M |
| April 02, 2024 | 54.09M |
| April 01, 2024 | 55.33M |
| Date | Value |
|---|---|
| March 28, 2024 | 49.87M |
| March 27, 2024 | 50.12M |
| March 26, 2024 | 50.37M |
| March 25, 2024 | 48.63M |
| March 22, 2024 | 50.37M |
| March 21, 2024 | 51.86M |
| March 20, 2024 | 49.13M |
| March 19, 2024 | 47.39M |
| March 18, 2024 | 47.89M |
| March 15, 2024 | 47.15M |
| March 14, 2024 | 46.90M |
| March 13, 2024 | 50.87M |
| March 12, 2024 | 53.10M |
| March 11, 2024 | 51.86M |
| March 08, 2024 | 49.38M |
| March 07, 2024 | 59.06M |
| March 06, 2024 | 60.05M |
| March 05, 2024 | 60.30M |
| March 04, 2024 | 59.42M |
| March 01, 2024 | 60.87M |
| February 29, 2024 | 60.99M |
| February 28, 2024 | 62.31M |
| February 27, 2024 | 63.52M |
| February 26, 2024 | 60.87M |
| February 23, 2024 | 60.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.67M
Minimum
Nov 09 2020
144.85M
Maximum
Feb 03 2021
68.56M
Average
67.09M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.742M |
| Palatin Technologies Inc | 33.32M |
| iBio Inc | 6.899M |
| Theriva Biologics Inc | 6.773M |
| Oragenics Inc | 4.884M |
Market Cap Related Metrics
| PS Ratio | 2.326 |
| Price to Book Value | 1.009 |
| Price | 2.03 |
| Earnings Yield | -23.65% |